Raspati C Koesoemadinata1, Susan M McAllister2, Nanny N M Soetedjo3, Dwi Febni Ratnaningsih1, Rovina Ruslami4, Sarah Kerry5, Ayesha J Verrall2, Lika Apriani1,6, Reinout van Crevel7, Bachti Alisjahbana1,3, Philip C Hill2. 1. TB-HIV Research Centre, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia. 2. Centre for International Health, Department of Preventive and Social Medicine, University of Otago, Dunedin 9054, New Zealand. 3. Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia. 4. Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia. 5. St George's, University of London, London SW17 ORE, UK. 6. Department of Public Health, Faculty of Medicine Universitas Padjadjaran, Bandung, Indonesia. 7. Department of Internal Medicine, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands.
Abstract
Background: Screening and treatment of latent TB infection (LTBI) and TB disease could reduce diabetes mellitus (DM)-associated TB. We aimed to describe the prevalence of LTBI and pulmonary TB among patients with DM in a TB-endemic setting. Methods: Patients with DM attending a hospital and community centres in Bandung, Indonesia, underwent LTBI screening using interferon gamma release assay (IGRA). TB was investigated by sputum smear, culture and x-ray. TB contacts from a parallel study were age- and sex-matched to patients with DM to compare LTBI and TB disease prevalence. Results: Of 682 patients with DM screened, 651 (95.5%) were eligible. Among 'TB disease-free' patients, LTBI prevalence was 38.9% (206/530; 95% CI 34.7-43.2). Patients with DM were less likely to be IGRA positive than TB contacts (38.6%, 54/140; 95% CI 30.5-46.6 vs 68.6%, 96/140; 95% CI 60.9-72.3: p<0.001); but had a higher disease prevalence (4.9%, 8/164; 95% CI 1.6-8.2 vs 1.2%, 2/164; 95% CI -0.5 to 2.9: p=0.054). Patients with DM in crowded households had increased risk of LTBI (AOR 1.71; 95% CI 1.19-2.45). Conclusions: LTBI prevalence in patients with DM was lower than in household contacts, but patients with DM were more likely to have TB disease. Further studies should explore possible benefits of LTBI screening and preventive therapy in patients with DM in TB-endemic settings.
Background: Screening and treatment of latent TB infection (LTBI) and TB disease could reduce diabetes mellitus (DM)-associated TB. We aimed to describe the prevalence of LTBI and pulmonary TB among patients with DM in a TB-endemic setting. Methods:Patients with DM attending a hospital and community centres in Bandung, Indonesia, underwent LTBI screening using interferon gamma release assay (IGRA). TB was investigated by sputum smear, culture and x-ray. TB contacts from a parallel study were age- and sex-matched to patients with DM to compare LTBI and TB disease prevalence. Results: Of 682 patients with DM screened, 651 (95.5%) were eligible. Among 'TB disease-free' patients, LTBI prevalence was 38.9% (206/530; 95% CI 34.7-43.2). Patients with DM were less likely to be IGRA positive than TB contacts (38.6%, 54/140; 95% CI 30.5-46.6 vs 68.6%, 96/140; 95% CI 60.9-72.3: p<0.001); but had a higher disease prevalence (4.9%, 8/164; 95% CI 1.6-8.2 vs 1.2%, 2/164; 95% CI -0.5 to 2.9: p=0.054). Patients with DM in crowded households had increased risk of LTBI (AOR 1.71; 95% CI 1.19-2.45). Conclusions: LTBI prevalence in patients with DM was lower than in household contacts, but patients with DM were more likely to have TB disease. Further studies should explore possible benefits of LTBI screening and preventive therapy in patients with DM in TB-endemic settings.
Authors: Leonardo Martinez; Limei Zhu; Maria E Castellanos; Qiao Liu; Cheng Chen; Benjamin D Hallowell; Christopher C Whalen Journal: Clin Infect Dis Date: 2017-11-29 Impact factor: 9.079
Authors: Frank Vrieling; Bachti Alisjahbana; Edhyana Sahiratmadja; Reinout van Crevel; Amy C Harms; Thomas Hankemeier; Tom H M Ottenhoff; Simone A Joosten Journal: Sci Rep Date: 2019-12-10 Impact factor: 4.379
Authors: Claudia Sala; Andrej Benjak; Delia Goletti; Sayera Banu; Jesica Mazza-Stadler; Katia Jaton; Philippe Busso; Sille Remm; Marion Leleu; Jacques Rougemont; Fabrizio Palmieri; Gilda Cuzzi; Ornella Butera; Valentina Vanini; Senjuti Kabir; S M Mazidur Rahman; Laurent Nicod; Stewart T Cole Journal: PLoS One Date: 2020-10-12 Impact factor: 3.240